Sign in
4

Changes in Ownership

Sarepta Therapeutics, Inc. Filed Acc 0001209191-22-017347

Chief Financial Officer gave up 1,706 shares (to pay taxes)

  • Chief Financial Officer acquired 8,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Estepan Ian Michael · Chief Financial Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2022-03-04 Shares withheld for taxes : show line 1 in the form −1,308 $79.20 $103,594 25,069 D
2022-03-07 Shares withheld for taxes : show line 2 in the form −398 $79.36 $31,585 24,671 D
2022-03-07 Grant or award : show line 3 in the form +8,000 32,671 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-03-07 Grant or award : show line 4 in the form Stock Option (right to sell) +48,000 48,000 D
Loading xslF345X03/doc4.xml…